Hong Chow

Hong Chow currently works at Merck KGaA, as Head-China & International Healthcare from 2021, Beiersdorf AG, as Member-Supervisory Board from 2017, Novo Nordisk A, as Executive VP-Product & Portfolio Strategy from 2026, and Shanghai Roche Pharmaceuticals Ltd., as General Manager from 2015.
Ms. Chow also formerly worked at Pixelpark AG, as Director-Investor Relations, Bayer Healthcare Co., Ltd., as Regional Managing Director-Strategic Market from 2012 to 2015, Bayer Group, as Regional Managing Director-Strategic Market from 2012 to 2015, Bayer Schering Pharma AG, as Senior Licensing Manager from 2001 to 2005, Bayer HealthCare AG, as Head-Regional Marketing from 2007 to 2010, Bayer (China) Ltd., as General Manager-Animal Health from 2011 to 2012, Roche (China) Investment Co., Ltd., as General Manager from 2015 to 2021, Bayer (South East Asia) Pte Ltd., as Head-Business Unit from 2010 to 2011, and Bayer Schering Pharma AG, as Senior Licensing Manager from 2001 to 2005.
Ms. Chow received her undergraduate degree from the University of Anglia Ruskin and undergraduate degree from Hochschule für Wirtschaft und Recht Berlin.